FR2442836A1 - 1,2,4,5-tetra-alkyl-4-arylpiperidines, leur preparation et leur utilisation therapeutique - Google Patents

1,2,4,5-tetra-alkyl-4-arylpiperidines, leur preparation et leur utilisation therapeutique

Info

Publication number
FR2442836A1
FR2442836A1 FR7928977A FR7928977A FR2442836A1 FR 2442836 A1 FR2442836 A1 FR 2442836A1 FR 7928977 A FR7928977 A FR 7928977A FR 7928977 A FR7928977 A FR 7928977A FR 2442836 A1 FR2442836 A1 FR 2442836A1
Authority
FR
France
Prior art keywords
arylpiperidines
tetra
alkyl
preparation
therapeutic use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7928977A
Other languages
English (en)
Other versions
FR2442836B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of FR2442836A1 publication Critical patent/FR2442836A1/fr
Application granted granted Critical
Publication of FR2442836B1 publication Critical patent/FR2442836B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

L'invention concerne des 4-arylpipéridines 1,2,4,5-tétrasubstituées de formule :
FR7928977A 1978-11-29 1979-11-23 1,2,4,5-tetra-alkyl-4-arylpiperidines, leur preparation et leur utilisation therapeutique Granted FR2442836A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/965,137 US4284635A (en) 1978-11-29 1978-11-29 Analgesic 1,2,4,5-tetra-alkyl-4-arylpiperidines

Publications (2)

Publication Number Publication Date
FR2442836A1 true FR2442836A1 (fr) 1980-06-27
FR2442836B1 FR2442836B1 (fr) 1983-07-29

Family

ID=25509504

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7928977A Granted FR2442836A1 (fr) 1978-11-29 1979-11-23 1,2,4,5-tetra-alkyl-4-arylpiperidines, leur preparation et leur utilisation therapeutique
FR8010755A Granted FR2453154A1 (fr) 1978-11-29 1980-05-13 Sels de tetrahydropyridinium, utiles comme intermediaires de synthese

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR8010755A Granted FR2453154A1 (fr) 1978-11-29 1980-05-13 Sels de tetrahydropyridinium, utiles comme intermediaires de synthese

Country Status (26)

Country Link
US (1) US4284635A (fr)
EP (1) EP0013078A3 (fr)
JP (1) JPS5573657A (fr)
KR (1) KR830001214A (fr)
AR (1) AR224138A1 (fr)
AT (1) ATA750879A (fr)
AU (1) AU529136B2 (fr)
BE (1) BE880220A (fr)
CA (1) CA1121357A (fr)
DD (1) DD147537A5 (fr)
DK (1) DK504979A (fr)
EG (1) EG14137A (fr)
ES (2) ES486425A0 (fr)
FI (1) FI793663A (fr)
FR (2) FR2442836A1 (fr)
GB (1) GB2038812B (fr)
GR (1) GR72292B (fr)
HU (1) HU178532B (fr)
IL (1) IL58793A0 (fr)
IT (1) IT1126406B (fr)
LU (1) LU81923A1 (fr)
PH (1) PH15420A (fr)
PL (1) PL123672B1 (fr)
PT (1) PT70486A (fr)
SU (1) SU967275A3 (fr)
ZA (1) ZA796336B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212183A (en) * 1981-11-14 1993-05-18 Basf Aktiengesellschaft 4-(p-tert.-butylphenyl)-3-methylpiperidines substituted at the nitrogen, their quaternary salts and their use as fungicides
US4485109A (en) * 1982-05-07 1984-11-27 E. I. Du Pont De Nemours And Company 4-Aryl-4-piperidinecarbinols
US4581456A (en) * 1983-09-21 1986-04-08 Eli Lilly And Company Processes for preparing picenadol precursors and novel intermediates thereof
ZW10287A1 (en) * 1986-07-15 1988-01-13 Hoffmann La Roche Tetrahydronaphthaline and indane derivatives
EP0299549A3 (fr) * 1987-07-09 1989-02-08 Duphar International Research B.V 3,5-Dialkyl-3-phényl-pipéridines avec une activité antagoniste des opiates
CA1337418C (fr) * 1988-03-28 1995-10-24 Engelbert Ciganek 4-aryl-4piperidine(ou pyrrolidine ou hexahydroazepine) cardinols et leurs analogues heterocycliques
US5136040A (en) * 1991-02-26 1992-08-04 Eli Lilly And Company Preparation of substituted tetrahydropyridines
US5250542A (en) * 1991-03-29 1993-10-05 Eli Lilly And Company Peripherally selective piperidine carboxylate opioid antagonists
US5270328A (en) * 1991-03-29 1993-12-14 Eli Lilly And Company Peripherally selective piperidine opioid antagonists
US5159081A (en) * 1991-03-29 1992-10-27 Eli Lilly And Company Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists
GB9912410D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912411D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912413D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912415D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912416D0 (en) * 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912417D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2956058A (en) * 1957-08-19 1960-10-11 Lilly Co Eli Novel substituted piperidines and pyrrolidines
US3080372A (en) * 1960-03-25 1963-03-05 Res Lab Dr C Janssen 1-aroylalkyl-4-arylpiperidine derivatives
US3574219A (en) * 1967-09-27 1971-04-06 Tanabe Seiyaku Co 1-(beta-hydroxyphenethyl)-2,3-dimethyl-3-(3-hydroxyphenyl)-piperidine
FR2224457A1 (fr) * 1973-04-05 1974-10-31 Ciba Geigy Ag
US4115400A (en) * 1976-05-27 1978-09-19 Eli Lilly And Company 1-Azoniabicyclo[3.1.0]hexanes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2892842A (en) * 1959-06-30 Their preparation
US3043845A (en) * 1958-12-29 1962-07-10 Abbott Lab Phenylmethylpiperidine derivatives
NL123743C (fr) * 1963-09-18
US3936468A (en) * 1969-10-27 1976-02-03 Sumitomo Chemical Company, Ltd. Phenylbutanol derivatives
AR206937A1 (es) * 1974-09-06 1976-08-31 Lilly Co Eli Procedimiento para preparar compuestos de 1-sustituido-4-alquil-4-fenil-piperidina
ZA777356B (en) * 1976-12-17 1979-01-31 Rohm & Haas Arthropod repellents

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2956058A (en) * 1957-08-19 1960-10-11 Lilly Co Eli Novel substituted piperidines and pyrrolidines
US3080372A (en) * 1960-03-25 1963-03-05 Res Lab Dr C Janssen 1-aroylalkyl-4-arylpiperidine derivatives
US3574219A (en) * 1967-09-27 1971-04-06 Tanabe Seiyaku Co 1-(beta-hydroxyphenethyl)-2,3-dimethyl-3-(3-hydroxyphenyl)-piperidine
FR2224457A1 (fr) * 1973-04-05 1974-10-31 Ciba Geigy Ag
US4115400A (en) * 1976-05-27 1978-09-19 Eli Lilly And Company 1-Azoniabicyclo[3.1.0]hexanes

Also Published As

Publication number Publication date
FR2442836B1 (fr) 1983-07-29
JPS5573657A (en) 1980-06-03
IL58793A0 (en) 1980-02-29
FR2453154A1 (fr) 1980-10-31
BE880220A (fr) 1980-05-23
AR224138A1 (es) 1981-10-30
GR72292B (fr) 1983-10-17
AU529136B2 (en) 1983-05-26
EP0013078A2 (fr) 1980-07-09
KR830001214A (ko) 1983-04-29
DK504979A (da) 1980-05-30
PL123672B1 (en) 1982-11-30
PL219885A1 (fr) 1980-12-01
AU5310079A (en) 1980-05-29
EG14137A (en) 1983-09-30
HU178532B (en) 1982-05-28
US4284635A (en) 1981-08-18
PH15420A (en) 1983-01-07
FI793663A (fi) 1980-05-30
CA1121357A (fr) 1982-04-06
FR2453154B1 (fr) 1983-05-27
IT1126406B (it) 1986-05-21
DD147537A5 (de) 1981-04-08
EP0013078A3 (fr) 1980-10-01
SU967275A3 (ru) 1982-10-15
IT7927614A0 (it) 1979-11-27
ES493915A0 (es) 1981-11-16
ES8101551A1 (es) 1980-12-16
GB2038812B (en) 1983-01-06
LU81923A1 (fr) 1980-04-22
GB2038812A (en) 1980-07-30
ATA750879A (de) 1983-03-15
PT70486A (en) 1979-12-01
ES486425A0 (es) 1980-12-16
ES8200664A1 (es) 1981-11-16
ZA796336B (en) 1981-06-24

Similar Documents

Publication Publication Date Title
FR2446832A1 (fr) Octahydro-pyrazolo(3,4-g)quinoleines et leur utilisation therapeutique
FR2430411A1 (fr) Phenethanolamines et leur utilisation therapeutique
FR2416891A1 (fr) 6-n-propyl-8-methoxymethyl ou methylmercaptomethylergolines et composes apparentes, et leur utilisation therapeutique
FR2417510A1 (fr) 9-amino- et imino-dibenzopyrannes et leur utilisation therapeutique
FR2400517A1 (fr) Triazolo-2,4-benzodiazepines et leur utilisation therapeutique
FR2417500A1 (fr) Derives d'amino-acides cycliques dehydrogenes et leur utilisation therapeutique
FR2442836A1 (fr) 1,2,4,5-tetra-alkyl-4-arylpiperidines, leur preparation et leur utilisation therapeutique
FR2446283A1 (fr) Phenoxyphenylpiperidines, leur preparation et leurs applications therapeutiques
FR2430408A1 (fr) Phenethanolamines optiquement actives et leur utilisation therapeutique
FR2385682A1 (fr) Nouveaux 1-amino-indanes et leur utilisation comme medicaments
FR2430409A1 (fr) Phenethanolamines et leur utilisation comme potentialisateurs des medicaments destructeurs des cellules cancereuses
FR2404629A1 (fr) Nouveaux tetrapeptides et leur utilisation therapeutique
FR2445329A1 (fr) Derives du 11-bromo-14-oxo-15-hydroxy-imino-e-homo-eburnane, leur preparation et leur utilisation comme medicament
FR2375253A1 (fr) Preparations de g-lactones d'acides 7x-(alcoxycarbonyl)-6x -alkyl/halog 17-hydroxy-3-oxo-17a -pregn-4-ene-21-carboxyliques, des acides 21-carboxyliques correspondants, de leurs sels et esters, et leur utilisation therapeutique comme diuretiques
FR2428629A1 (fr) Nouveaux composes bis(aryloxycarboxyliques), leur preparation et leur utilisation en therapeutique
FR2417499A1 (fr) Mercaptoacylamino-acides halogenes et leur utilisation therapeutique
FR2385707A1 (fr) 3-amino-6,7-dialcoxy-1h-1,2,4-benzothiadiazine-1-oxydes 1-substitues et leur utilisation comme medicaments
FR2361345A1 (fr) Homologues de somatostatine, sa preparation et son utilisation therapeutique
FR2446833A1 (fr) Octahydro-2h-pyrrolo(3,4-g)quinoleines et leur utilisation therapeutiques
FR2434805A1 (fr) 1-benzoyl-3-pyridinylurees, leur preparation et leur utilisation comme insecticides
FR2428047A1 (fr) Arylalkyl- et aryloxyalkyl- phosphonates, leur preparation et leur utilisation therapeutique
FR2419291A1 (fr) 2,3-dihydroimidazo(1,2-c)pyrimidines substituees et leur utilisation therapeutique
FR2399406A1 (fr) Derives de perhydronaphtalenepentol et leur utilisation therapeutique
FR2430407A1 (fr) R-n-(2-phenyl-2-hydroxyethyl)-3-phenylpropylamines et leur utilisation therapeutique
FR2363541A1 (fr) Acyloxy-n,n' diacylmalonamides et leur mode de preparation

Legal Events

Date Code Title Description
ER Errata listed in the french official journal (bopi)

Free format text: 31/80

ST Notification of lapse